244 related articles for article (PubMed ID: 17936689)
1. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy.
Kossoff EH; Los JG; Boatman DF
Epilepsy Behav; 2007 Dec; 11(4):514-7. PubMed ID: 17936689
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood.
von Stülpnagel C; Kluger G; Leiz S; Holthausen H
Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383
[TBL] [Abstract][Full Text] [Related]
3. Language dysfunction in children with Rolandic epilepsy.
Staden U; Isaacs E; Boyd SG; Brandl U; Neville BG
Neuropediatrics; 1998 Oct; 29(5):242-8. PubMed ID: 9810559
[TBL] [Abstract][Full Text] [Related]
4. Cognitive deficits in children with benign rolandic epilepsy of childhood or rolandic discharges: a study of children between 4 and 7 years of age with and without seizures compared with healthy controls.
Danielsson J; Petermann F
Epilepsy Behav; 2009 Dec; 16(4):646-51. PubMed ID: 19879197
[TBL] [Abstract][Full Text] [Related]
5. Acoustic effects of carbamazepine in benign rolandic epilepsy.
Park JI; Kim SJ; Kim HG
Epilepsy Behav; 2005 Nov; 7(3):468-71. PubMed ID: 16140591
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
[TBL] [Abstract][Full Text] [Related]
7. The neuropsychological and language profile of children with benign rolandic epilepsy.
Northcott E; Connolly AM; Berroya A; Sabaz M; McIntyre J; Christie J; Taylor A; Batchelor J; Bleasel AF; Lawson JA; Bye AM
Epilepsia; 2005 Jun; 46(6):924-30. PubMed ID: 15946332
[TBL] [Abstract][Full Text] [Related]
8. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
9. The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
Mintz M; Legoff D; Scornaienchi J; Brown M; Levin-Allen S; Mintz P; Smith C
J Child Neurol; 2009 Jul; 24(7):807-15. PubMed ID: 19189934
[TBL] [Abstract][Full Text] [Related]
10. Specific language impairment versus Landau-Kleffner syndrome.
Billard C; Fluss J; Pinton F
Epilepsia; 2009 Aug; 50 Suppl 7():21-4. PubMed ID: 19682045
[TBL] [Abstract][Full Text] [Related]
11. Written language skills in children with benign childhood epilepsy with centrotemporal spikes.
Papavasiliou A; Mattheou D; Bazigou H; Kotsalis C; Paraskevoulakos E
Epilepsy Behav; 2005 Feb; 6(1):50-8. PubMed ID: 15652734
[TBL] [Abstract][Full Text] [Related]
12. Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: rolandic epilepsy and language.
Monjauze C; Tuller L; Hommet C; Barthez MA; Khomsi A
Brain Lang; 2005 Mar; 92(3):300-8. PubMed ID: 15721962
[TBL] [Abstract][Full Text] [Related]
13. Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame.
Wirrell E; Sherman EM; Vanmastrigt R; Hamiwka L
J Child Neurol; 2008 Jan; 23(1):14-21. PubMed ID: 18184938
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy.
Weber S; Beran RG
J Clin Neurosci; 2004 Sep; 11(7):728-31. PubMed ID: 15337134
[TBL] [Abstract][Full Text] [Related]
15. Association of language dysfunction and age of onset of benign epilepsy with centrotemporal spikes in children.
Jurkevičienė G; Endzinienė M; Laukienė I; Šaferis V; Rastenytė D; Plioplys S; Vaičienė-Magistris N
Eur J Paediatr Neurol; 2012 Nov; 16(6):653-61. PubMed ID: 22560726
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam in absence epilepsy.
Verrotti A; Cerminara C; Domizio S; Mohn A; Franzoni E; Coppola G; Zamponi N; Parisi P; Iannetti P; Curatolo P
Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
19. Landau-Kleffner syndrome responsive to levetiracetam.
Kossoff EH; Boatman D; Freeman JM
Epilepsy Behav; 2003 Oct; 4(5):571-5. PubMed ID: 14527502
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam reduces the frequency of interictal epileptiform discharges during NREM sleep in children with ADHD.
Bakke KA; Larsson PG; Eriksson AS; Eeg-Olofsson O
Eur J Paediatr Neurol; 2011 Nov; 15(6):532-8. PubMed ID: 21683631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
